Verywell Health on MSN40m
Zepbound Cuts the Risk of Progressing to Diabetes by 94%, Eli Lilly Data Shows
Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...
European committee takes a second look at Alzheimer's drug and now says it should be approved
A European regulatory committee now recommends approval of the Alzheimer's treatment lecanemab a few months after rejecting ...
WOFL53m
New FDA rules target those ubiquitous TV drug commercials
The agency’s new guidelines are created to eliminate pharmaceutical company practices that minimize or distract consumers ...